Clinical Trial Update: Safety of Ovarian Stimulation With Letrozole and Gonadotropins in Breast Cancer Patients [NA]

View source ↗

Summary

The clinical trial evaluating safety of ovarian stimulation with letrozole and gonadotropins in breast cancer patients has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• FEMARA (letrozole)
• Gonadotropins (gonadotropins)

Snippet

Sponsor: New York Medical College | Conditions: Breast Cancer | NA | Status: TERMINATED